Education
About Us
Working with TipRanks
Follow Us
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.02M | $ 6.88M | $ 2.36M | $ 4.65M | $ 7.42M |
| Gross Profit | $ -156.53M | $ -111.13M | $ -79.90M | $ -48.66M | $ -35.12M |
| Operating Income | $ -195.08M | $ -154.54M | $ -115.23M | $ -71.24M | $ -63.35M |
| EBITDA | $ -191.90M | $ -139.03M | $ -104.20M | $ -66.08M | $ -45.64M |
| Net Income | $ -157.86M | $ -141.43M | $ -112.33M | $ -70.51M | $ -59.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 725.28M | $ 421.70M | $ 304.95M | $ 408.25M | $ 194.42M |
| Total Assets | $ 792.34M | $ 465.63M | $ 352.74M | $ 444.65M | $ 235.84M |
| Total Debt | $ 3.81M | $ 2.54M | $ 4.03M | $ 3.04M | $ 3.48M |
| Net Debt | $ -24.54M | $ -32.27M | $ -25.40M | $ -36.10M | $ -40.35M |
| Total Liabilities | $ 45.34M | $ 36.46M | $ 26.53M | $ 25.18M | $ 26.48M |
| Stockholders' Equity | $ 747.00M | $ 429.17M | $ 326.20M | $ 419.48M | $ 209.36M |
| Cash Flow | |||||
| Free Cash Flow | $ -159.70M | $ -109.11M | $ -105.56M | $ -62.16M | $ -41.96M |
| Operating Cash Flow | $ -157.78M | $ -107.29M | $ -103.73M | $ -60.91M | $ -40.40M |
| Investing Cash Flow | $ -290.13M | $ -105.78M | $ 89.94M | $ -216.16M | $ -98.22M |
| Financing Cash Flow | $ 441.45M | $ 218.46M | $ 4.08M | $ 272.37M | $ 171.23M |